Bioventus Inc.
- Last sale
- Nov 12, 2026 · -1.09%
- Market cap
- $916.34M
- 84.26M shares
- Filings
- 464
Q3 2026−0.9% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derived+90.8% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+23.2% FY25 yoy
- $916.34M
- 16.0×
- 1.6×
- 3.8×
- 9.27%
- —
Twelve months to Sep 26, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $568,087,000 | reported | |
| FY 2024 | 2024-12-31 | $573,280,000 | reported | |
| FY 2023 | 2023-12-31 | $512,345,000 | reported | |
| FY 2022 | 2022-12-31 | $512,117,000 | reported | |
| FY 2021 | 2021-12-31 | $430,898,000 | reported | |
| FY 2020 | 2020-12-31 | $321,161,000 | reported | |
| FY 2019 | 2019-12-31 | $340,141,000 | reported |
Segments
LineFY2025ShareChange
U.S.$502.10M88%−0.9%
International$65.99M12%−0.7%
Total$568.09M
Surgical & medical instruments & apparatus
Bioventus Inc. is the 28th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
ATECAlphatec Holdings, Inc.$764.2M25.0%18.8%$1.1BIRTCiRhythm Holdings, Inc.$747.1M26.2%6.0%$4.2BNVCRNovoCure Ltd$655.4M8.3%20.8%$1.4BUFPTUFP Technologies Inc$602.8M19.5%11.3%$2.4B
BVSBioventus Inc. (this company)$568.1M0.9%4.0%$916.3M
ATRCAtriCure, Inc.$534.5M14.9%2.1%$2.9BGKOSGlaukos Corp$507.4M32.3%37.0%$14.6BAORTArtivion, Inc.$441.3M13.6%2.2%$945.5MMDXGMimedx Group, Inc.$418.6M20.0%11.6%$471.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Bioventus Inc. · CIK 1665988 · Engraved from SEC EDGAR